ArticleCureus2025
Decades in the Making: A Rare Case of Mastoid Squamous Cell Carcinoma Following Chronic Otitis Media and Mastoidectomy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Squamous cell carcinoma (SCC) of the mastoid, a subtype of temporal bone SCC (TBSCC), is a rare and aggressive malignancy often associated with chronic otologic conditions such as chronic otitis media (COM) and mastoiditis. We present the case of a 67-year-old male with a lifelong history of COM and a childhood mastoidectomy who developed SCC of the right mastoid decades later. The patient developed worsening otologic symptoms, including persistent bloody ear discharge that ultimately led to diagnosis via mastoid biopsy. Surgical resection revealed poorly differentiated SCC involving the mastoid, middle ear, and adjacent structures, with positive margins due to tumor adherence to the dura. The patient was treated with adjuvant radiation and cisplatin-based chemotherapy, resulting in no evidence of recurrence or metastasis at follow-up. This case shows that chronic ear disease can, in rare instances, progress to malignancy and reminds clinicians to stay alert when otologic symptoms worsen or persist. It also illustrates the importance of early biopsy and imaging in differentiating benign chronic inflammation from malignant transformation. Despite incomplete resection, the patient's favorable response to multiple forms of therapy suggests that aggressive combined treatment can still give meaningful disease control. Increased awareness, early diagnosis, and comprehensive management strategies are critical to improving outcomes in patients at risk for TBSCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.